Siga Technologies (SIGA) Net Income towards Common Stockholders Growth (5y) (2015 - 2025)
Siga Technologies (SIGA) Net Income towards Common Stockholders Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Siga Technologies | 212.67 Mn | 57.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -17.75% |
| Jun 30, 2025 | 11.17% |
| Mar 31, 2025 | 47.05% |
| Dec 31, 2024 | 62.97% |
| Sep 30, 2024 | 21.19% |
| Jun 30, 2024 | 19.83% |
| Mar 31, 2024 | 54.57% |
| Dec 31, 2023 | 6.64% |
| Sep 30, 2023 | -14.88% |
| Jun 30, 2023 | 16.42% |
| Mar 31, 2023 | 39.77% |
| Dec 31, 2022 | 39.84% |
| Sep 30, 2022 | 39.94% |
| Jun 30, 2022 | 17.76% |
| Mar 31, 2022 | 46.98% |
| Dec 31, 2021 | 55.29% |
| Sep 30, 2021 | 19.56% |
| Jun 30, 2021 | 51.42% |
| Mar 31, 2021 | 30.20% |
| Dec 31, 2020 | 24.60% |